Aldeyra Therapeutics, Inc. (ALDX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.480.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ALDX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||||||||
| R&D Expenses | 15.6 | 25.7 | 48.2 | 29.5 | 47.3 | 44.9 | 24.7 | 44.4 | 29.8 | 16.3 | 13.2 | 7.6 | 3.7 |
| Operating Income | (24.1) | (35.3) | (60.1) | (42.8) | (62.7) | (56.2) | (36.4) | (63.1) | (39.7) | (22.5) | (18.7) | (12.0) | (7.3) |
| Earnings from Continuing Operations | |||||||||||||
| Interest Expense | — | 1.9 | 1.9 | 2.1 | 1.7 | 1.7 | 1.9 | 0.6 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 |
| Interest & Investment Income | 2.4 | 3.3 | 6.2 | 7.3 | 2.3 | 0.2 | 0.3 | 1.5 | 1.0 | 0.3 | 0.1 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | (5.3) | (0.7) | 1.6 | 1.6 | (0.9) | (0.8) | (0.1) | 0.0 | 0.1 | 0.2 |
| Other Non-Operating Income / Expenses | 1.0 | 1.4 | 4.3 | 5.3 | 0.7 | (1.6) | (1.6) | 0.9 | 0.8 | 0.1 | (0.0) | (0.1) | 2.1 |
| EBT, Incl. Unusual Items | — | — | — | — | — | (57.8) | (38.0) | (62.1) | — | — | — | — | — |
| Income Tax Expense | — | — | 0.0 | 0.0 | 0.0 | 0.0 | (0.5) | (1.3) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||||||||
| Net Income | (23.1) | (33.8) | (55.9) | (37.5) | (62.0) | (57.8) | (37.6) | (60.8) | (38.9) | (22.3) | (18.7) | (12.1) | (5.2) |
| Per Share | |||||||||||||
| Basic EPS | (0.38) | (0.56) | (0.94) | (0.64) | (1.06) | (1.07) | — | — | — | — | — | (1.40) | (2.51) |
| Diluted EPS | (0.38) | (0.56) | (0.94) | (0.64) | (1.06) | (1.07) | — | — | — | — | — | (1.40) | (3.09) |
| Basic Weighted Avg Shares | 60.3 | 60.1 | 59.5 | 58.9 | 58.4 | 54.0 | — | — | — | — | — | 8.6 | 3.8 |
| Diluted Weighted Avg Shares | 60.3 | 60.1 | 59.5 | 58.9 | 58.4 | 54.0 | — | — | — | — | — | 8.6 | 3.9 |
| Supplemental | |||||||||||||
| EBIT | (24.1) | (35.3) | (60.1) | (42.8) | (62.7) | (56.2) | (36.4) | (63.1) | (39.7) | (22.5) | (18.7) | (12.0) | (7.3) |
| Effective Tax Rate | — | — | — | — | — | 0.0% | 1.3% | 2.1% | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.